chartexchange

VXRT
VAXART INC
stockOTC

EODOct 2, 2026
0.437USD-0.682%(-0.003)239,377
Loading…
Loading…
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$0.44
Beta
0.83
52-Week High
$0.84 2026-01-12
52-Week Low
$0.31 2025-11-04
SMA 50
$0.50
SMA 200
$0.59
Avg. Vol 10D
263,258
Avg. Vol 30D
272,533
Avg. Vol 90D
306,218
Relative Vol
0.88
228.22M
238.37M
126
Feb 14, 2018 · 1-for-11 (reverse)
VXRT Profile

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company's proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.

VXRT Performance
PeriodPriceDateChangeBeta
1W0.462026-09-28-4.54%0.037
1M0.502026-09-04-11.72%1.281
3M0.622026-07-06-29.17%1.706
6M0.632026-04-06-30.49%0.846
1Y0.362025-10-03+20.55%0.827
2Y0.812024-10-04-46.20%—
5Y6.962021-10-04-93.72%1.664
VXRT Stock Summary

VAXART INC (OTC:VXRT) stock price today is $0.44, and today's volume is 239,377. VXRT is down 0.682% today. The 30 day average volume is 272,533. VXRT market cap is $99.73M with 228.22M shares outstanding.